{
    "nct_id": "NCT04737577",
    "official_title": "Phase II Pilot Randomized Controlled Trial to Assess Feasibility of \"Supra-marginal\" Surgical Resection of Malignant Glioma",
    "inclusion_criteria": "1. Radiographic evidence of a GAD-enhancing intra-axial tumor consistent with HGG;\n2. Age ≥18 ≤ 85 years;\n3. Karnofsky Performance Score ≥ 60;\n4. Location of tumor in a safe anatomical location and\n5. Patient or substitute decision maker (SDM) able to understand and consent to study participation.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 85 Years",
    "exclusion_criteria": "1. Multi-focal tumor, gliomatosis cerebri (≥3 lobes of the brain affected), tumors crossing the midline, or leptomeningeal enhancement;\n2. Previous craniotomy for tumor excision (stereotactic biopsy is permitted);\n3. Known metastatic cancer;\n4. Uncorrectable coagulopathy;\n5. Unable to obtain GAD-enhanced brain MRI.",
    "miscellaneous_criteria": ""
}